# clm_CBD2A7149F84

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: quarterly_revenue  
value: 5,138,500,000 United States dollar  
valid_from: 2021-06-30  
valid_to: 2021-09-30  
published: 2021-08-05  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_FC7E3BF6DC06  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals quarterly revenue: 5,138,500,000 United States dollar", as of 2021-06-30 (until 2021-09-30). Claim clm_CBD2A7149F84, https://asof.is/claim/clm_CBD2A7149F84, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000180422021000025/0001804220-21-000025-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q2 FY2021, filed 2021-08-05  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000180422021000025/0001804220-21-000025-index.htm (primary, SEC EDGAR 10-Q Q2 FY2021, published 2021-08-05)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 2,528,700,000 United States dollar | valid 2021-03-31 to 2021-06-30 | conf 0.95 | superseded | superseded_by [clm_CBD2A7149F84](/claim/clm_CBD2A7149F84.md) | [clm_9488B81B5C8C](/claim/clm_9488B81B5C8C.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.